Cancer news

Latest news, press releases and blog posts from Cancer Research UK.


Let the right ones in – boosting immunotherapy for pancreatic cancer

Research published today in Cancer Cell might open up a way through pancreatic tumours’ defences.

Scientists tear down pancreatic cancer's defences

Glasgow researchers have shown an experimental drug that blocks CXCR2 can improve survival in mice when given with immunotherapy drugs.

Tackling brain tumours, understanding immunotherapy and revealing cancer’s genetics at the end of life – accelerating progress at our Centres

We've announced four new awards to speed up research in our Centres, particularly for cancers where survival is still poor.

More pieces of the jigsaw fall into place at the 2016 AACR Conference

We look back on the key topics and trends discussed at the American Association of Cancer Research's recent Annual Meeting in New Orleans

Studies show continued promise for immunotherapy drugs

Several new immunotherapy drugs are continuing to show benefits across a range of cancer types, according to data presented at a US conference.

Gene editing technology could help engineer better cancer targeting immune cells

We explore how the latest gene editing technology could help our scientists engineer immune cells to precisely target and kill cancer cells.

Blood analysis could offer a real-time ‘snapshot’ of melanoma treatment

We explore the latest research from our scientists in Manchester that's tracking how melanomas respond to treatment by analysing patient blood samples.

Cancer ‘master control switch’ could help tumours hide from immune system

Scientists have found a crucial link between a gene often found to be overactive in cancer cells, and tumours’ ability to hide from the immune system.

New immunotherapy discovery could give treatments the precision they need

Our scientists may have uncovered the 'guidance system' needed to make cancer immunotherapy more effective.

Tumours contain the seeds of their own destruction

Scientists have made a groundbreaking discovery in understanding how the genetic complexity of tumours can be recognised and exploited by the immune system.